Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tablet
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Dental Pain
Conditions
Post-operative Dental Pain
Trial Timeline
Aug 13, 2018 → Apr 15, 2019
NCT ID
NCT03566979About Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tablet
Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tablet is a phase 3 stage product being developed by Johnson & Johnson for Post-operative Dental Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT03566979. Target conditions include Post-operative Dental Pain.
What happened to similar drugs?
4 of 11 similar drugs in Post-operative Dental Pain were approved
Approved (4) Terminated (0) Active (7)
🔄Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03566979 | Phase 3 | Completed |
Competing Products
18 competing products in Post-operative Dental Pain